High dose epirubicin chemotherapy in untreated poorer prognosis small cell lung cancer
- 1 May 1990
- journal article
- research article
- Published by Elsevier in Respiratory Medicine
- Vol. 84 (3), 241-244
- https://doi.org/10.1016/s0954-6111(08)80042-x
Abstract
No abstract availableThis publication has 7 references indexed in Scilit:
- Etoposide compared with the combination of vincristine, doxorubicin, and cyclophosphamide in the treatment of small cell lung cancer.Thorax, 1989
- Survival, adverse reactions and quality of life during combination chemotherapy compared with selective palliative treatment for small-cell lung cancer: Report to the medical research council by its lung cancer working partyRespiratory Medicine, 1989
- Pretreatment prognostic factors and scoring system in 407 small‐cell lung cancer patientsInternational Journal of Cancer, 1987
- THE IMPACT OF CHEMOTHERAPY ON SMALL CELL-CARCINOMA OF THE BRONCHUS1986
- Epirubicin: a review of the pharmacology, clinical activity, and adverse effects of an adriamycin analogue.Journal of Clinical Oncology, 1986
- PROGNOSTIC-SIGNIFICANCE OF LABORATORY PARAMETERS MEASURED AT DIAGNOSIS IN SMALL CELL-CARCINOMA OF THE LUNG1985
- 4′-epi-doxorubicin, a new analogue of doxorubicin: a preliminary overview of preclinical and clinical dataCancer Treatment Reviews, 1983